静脉直径与临床严重程度及生活质量的关系:一项系统综述
多数研究显示静脉直径与CEAP分级呈正相关,但与VCSS仅弱相关,且与HRQoL评分无显著关系。结论提示静脉直径与临床严重程度相关,但不能预测HRQoL,不应作为决定静脉干预的指标。
要点
- 静脉直径与CEAP分级呈正相关,但多数研究未纳入C0和C1期患者。
- 静脉直径与VCSS仅呈弱相关,与HRQoL评分无显著关系。
- 静脉直径不应作为决定是否需要静脉干预的指标。
核心结论
- 现有文献提示躯干静脉直径与临床严重程度相关,但证据等级有待提高。
- 静脉直径对HRQoL的预测能力差,与患者感知的慢性静脉疾病影响无关系。
- 静脉直径不应被用作决定谁需要静脉干预的衡量标准。
研究设计与样本
- 系统综述,遵循PRISMA指南,检索MEDLINE和Embase数据库(1946年至2018年8月31日)。
- 纳入报告大隐静脉和小隐静脉直径与临床严重程度和/或HRQoL评分关系的英文全文研究,所有研究设计均纳入。
- 两名评价者独立进行研究选择、数据提取和偏倚风险评估。
主要发现
- 4项研究将躯干静脉直径与临床严重程度和HRQoL同时进行相关性分析,7项仅报告临床严重程度指标。
- 7项研究评估了与CEAP分级的关系,其中多数观察到静脉直径与疾病严重程度呈正相关。
- 4项研究发现与VCSS呈弱相关,其中1项显示与VCSS组分相关。
- 未报告静脉直径与HRQoL评分之间存在显著关系。
- 1项研究还显示与治疗后Aberdeen静脉曲张问卷改善无相关性。
临床怎么用
- 临床中不应仅依据静脉直径决定是否对慢性静脉疾病患者进行静脉干预。
- 评估慢性静脉疾病严重程度时可参考静脉直径与CEAP分级的正相关关系,但需结合其他指标。
- 静脉直径不能反映患者HRQoL,决策时应重视患者报告的生活质量结局。
局限性
- 大多数研究未纳入C0和C1期参与者,可能限制结论的普遍性。
- 研究使用了多种不同的HRQoL和临床严重程度测量工具,影响结果的可比性。
- 现有文献的证据等级有待提高,需要进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE/BACKGROUND: The aim was to summarise the evidence for the relationship between vein diameters and clinical severity, and elucidate the relationship between diameters and health related quality of life (HRQoL) METHODS: A systematic review was performed according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) guidelines. The MEDLINE and Embase databases were searched from 1946 to 31 August 2018. Reference lists of included studies were searched for further relevant papers. Full text studies in English reporting the relationship between great and small saphenous vein diameters and clinical severity and/or HRQoL scores measured using validated instruments were included. All study designs were included. Studies that did not include relationships between these parameters, non-English studies, and studies focusing on non-truncal veins were excluded. Two reviewers independently performed the study selection, data extraction, and risk of bias assessment. RESULTS: Eleven eligible studies were identified, reporting on 2,732 limbs (range 22-681). Four studies correlated truncal vein diameter with both clinical severity and HRQoL, while seven reported only on clinical severity measures. Multiple instruments were used to quantify HRQoL and clinical severity. Seven studies assessed the relationship with CEAP class, with the majority observing a positive correlation between vein diameter and disease severity. Four studies found weak correlations with VCSS, with one showing correlations with VCSS components. No significant relationship between diameters and HRQoL scores was reported. One study also revealed no correlation with Aberdeen Varicose Vein Questionnaire improvements post-treatment. The majority of studies failed to include C0 and C1 participants. CONCLUSIONS: While further studies are required to improve the level of evidence, the existing literature suggests that truncal vein diameters correlate with clinical severity. Diameters are a poor predictor of HRQoL, with no relationship to patients' perceived impact of chronic venous disease. As such, vein diameter should not be used as a measure to decide who needs venous intervention.
引用
- Tan MKH, Sutanto SA, Onida S, et al. The Relationship Between Vein Diameters, Clinical Severity, and Quality of Life: A Systematic Review. Eur J Vasc Endovasc Surg. 2019. PMID: 30850282. doi:10.1016/j.ejvs.2019.01.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。